Evidence map›Paper›PMID 32309814›Full record

ArticleThe Lancet. Rheumatology2020

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.

Milena A Gianfrancesco, Kimme L Hyrich, Laure Gossec, Anja Strangfeld, Loreto Carmona, Elsa F Mateus, Paul Sufka, Rebecca Grainger, Zachary Wallace, Suleman Bhana and 8 more

2 registry-linked trialsAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 123 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04397237 unknown statusnot on this map

Prevalence, Seroconversion and Impact of COVID-19 in Autoimmune Diseases in Europe

TypeobservationalSponsorPitié-Salpêtrière HospitalRan2020 to 2021Enrolled3,100ConditionsCOVID-19, Systemic Lupus Erythematosus, Sjogren's Syndrome, Axial Spondyloarthritis
NCT04426279 terminatednot on this map

Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants

TypeobservationalSponsorUniversity Hospital, LilleRan2020 to 2021Enrolled539ConditionsSars-CoV2, Rheumatoid Arthritis, Rheumatic DiseasesArmsquestionnaire assesment
3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Milena A GianfrancescoDivision of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, 94143 CA, USA.
Kimme L HyrichCentre for Epidemiology Versus Arthritis, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Laure GossecSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris France.
Anja StrangfeldEpidemiology Unit, German Rheumatism Research Center (DRFZ Berlin), Berlin, Germany.
Loreto CarmonaInstituto de Salud Musculoesquelética, Madrid, Madrid, Spain.
Elsa F MateusPortuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.
Paul SufkaHealthpartners, St. Paul, MN, USA.
Rebecca GraingerDepartment of Medicine, University of Otago, Dunedin, Otago, New Zealand.
Zachary WallaceMassachusetts General Hospital and Program in Rheumatology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Suleman BhanaCrystal Run Health, Middletown, NY, USA.
Emily SirotichDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Jean LiewDivision of Rheumatology, University of Washington, Seattle, WA, USA.
Jonathan S HausmannDivision of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Wendy CostelloIrish Children's Arthritis Network (iCAN), Tipperary, Ireland.
Philip RobinsonUniversity of Queensland Faculty of Medicine, Brisbane, QLD, Australia.
Pedro M MachadoCentre for Rheumatology and Department of Neuromuscular Diseases, University College London, London, UK.
Jinoos YazdanyDivision of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, 94143 CA, USA.
COVID-19 Global Rheumatology Alliance Steering Committee

Funding

RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2M
Advancing Quality and Outcomes Measurement in RheumatologyK24AR074534 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jinoos Yazdany · 2019 to 2026
$1.5M
Computational methods using electronic health records and registry data to detect and predict clinical outcomes in rheumatic diseaseK01AR075085 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GIANFRANCESCO, MILENA ANNE · 2019 to 2022
$458k
Examining the causal effect of sociodemographic and genetic factors on patient safety outcomes in individuals prescribed high-risk immunosuppressive medicationsF32AR070585 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GIANFRANCESCO, MILENA ANNE · 2017 to 2018
$125k
NIAMS NIH HHS F32 AR070585NIAMS NIH HHS K01 AR075085NIAMS NIH HHS K24 AR074534NIAMS NIH HHS P30 AR070155
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32309814
PMCPMC7162647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.